Resistance to β-lactams is an increasing problem. This review outlines various approaches taken to discover MBL inhibitors, with an emphasis on the different chemical classes of inhibitors.
Browsing: Clinical > Antimicrobial Resistance
Researchers have uncovered metabolic changes in Mycobacterium tuberculosis, which may enable the bacteria to withstand exposure to antimicrobials, suggesting that targeting these pathways could reduce treatment times.
The lack of viable antibiotics has urged researchers to think of new approaches to treat deadly bacterial infections. This editorial discusses the progress so far, and the future applications, of strategies involving predatory bacteria.
Antivirulence agents represent an attractive alternative to antibiotics. Here, the authors discuss the advantages, and the gaps in antivirulence therapy.
A novel type of wound dressing that combines both hydrogel dressings and chitosan could reduce the risk of bacterial infection in recovering patients.
A novel, bioinspired antimicrobial treatment, consisting of iodo-thiocyanate complexes, has demonstrated promising results as a bactericidal compound, according to new research.
In this editorial the authors offer a perspective about issues surrounding the implementation of molecular antibiograms in the diagnostic workflow.
New research suggests it may be possible to quickly and accurately diagnose drug-resistant bacteria utilizing equipment already owned by hospitals.
Components from bacteria-infecting viruses could allow scientists to create hybrid human antibodies that can target carbohydrate molecules found on bacterial cell surfaces.